Pharmaceutical Report Library l Report Store l Pharma Intelligence

France, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and interventional procedures in France

November 1, 2012

Find out more

Germany, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and interventional procedures in Germany; incidence and prevalence figures are compared with those of the Benelux countries

November 1, 2012

Find out more

Italy, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and procedures in Italy; incidence and prevalence figures are compared with those of the Benelux countries

November 1, 2012

Find out more

Spain, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and procedures in Spain; incidence and prevalence figures are compared with those of the Benelux countries

November 1, 2012

Find out more

United Kingdom, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in the United Kingdom (U.K.); incidence and prevalence figures are compared with those of the Benelux countries

December 3, 2012

Find out more

Germany, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Germany; incidence and prevalence figures are compared with those of the Benelux countries

December 3, 2012

Find out more

Italy, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Italy; incidence and prevalence figures are compared with those of the Benelux countries

December 3, 2012

Find out more

Spain, Neurological Market Opportunities: Disease Incidence and Prevalence, And Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Spain

December 3, 2012

Find out more

United States, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the prevalence and number of hospital discharges in the UnitedStates (U.S.) as well as the surgical procedure volumes for selected cardiovascular/thoracic diseases/disorders.

January 1, 2013

Find out more

United States, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the prevalence and number of hospital discharges in the United States (U.S.) as well as the surgical procedure volumes for selected musculoskeletal diseases/disorders.

January 1, 2013

Find out more

United States, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the prevalence and number of hospital discharges in the United States (U.S.) as well as the surgical procedure volumes for selected neurological diseases/disorders.

January 1, 2013

Find out more

U.S. Markets for Skin Replacements and Substitutes and Active Wound Repair Modulators

$3,750.00

The scope of this report includes tissue-engineered skin replacements and substitutes (i.e., epidermal equivalents, dermal equivalents, and multilayer equivalents) and active wound repair modulators.

February 1, 2013

Find out more

Current and Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Therapies

$4,750.00

Approximately 16.3 million adults in the United States (U.S.) suffer from coronaryheart disease (CHD), a type of cardiovascular disease that is associated with areduction in blood flow through the vasculature of the heart (ischemic heart disease).

March 1, 2013

Find out more

U.S. Markets for Diagnostic Oncology-Related X-Ray-Based Imaging Products

$3,750.00

Discoveries in molecular medicine in recent years have allowed researchers to study the genetic/chromosomal alterations that trigger the transformation of normal cells into malignant cells, which ultimately has led to the understanding that cancer—of which there are more than 100 forms—is a disease of the cellular genome.

March 1, 2013

Find out more

U.S. Markets for Compression Therapy and Pressure Reduction and Relief Products Used for Wound Management

$3,750.00

The scope of this report includes compression therapy products (e.g., compression bandages, compression stockings, and pneumatic compression devices) and pressure reduction and relief products (e.g., specialty/integrated beds, mattress replacements, and mattress overlays).

April 1, 2013

Find out more

U.S. Benign Uterine Conditions Therapy Systems Market

$3,750.00

This report presents an overview of the most common types of treatment for the benign uterine conditions of menorrhagia and uterine fibroids/polyps; among these therapies are dilation and curettage, hysterectomy, hysteroscopy, and myomectomy. Market and competitive analyses for the medical devices used in these treatments also are presented.

May 1, 2013

Find out more

U.S. Markets for Orthopedic Biomaterials for Bone Repair and Regeneration

$3,750.00

The United States (U.S.) market for orthopedic biomaterials for bone repair and regeneration, as covered by the scope of this report

May 1, 2013

Find out more

European Markets for Prosthetic Vascular Grafts

$3,850.00

Prosthetic vascular grafts, made of synthetic or biological materials, are used to bypass or replace segments of blood vessels in kidney failure patients requiring hemodialysis access as well as those undergoing treatment for aneurysms or vascular occlusions.

July 1, 2013

Find out more

U.S. Markets for Orthopedic Biomaterials for Viscosupplementation and Cartilage, Ligament/Tendon, and Meniscal Repair and Regeneration

$3,750.00

The United States (U.S.) market for orthopedic biomaterials, as covered by the scope of this report, comprises bioresorbable fixation devices, visco supplementation products, cartilage repair and regeneration technologies.

July 1, 2013

Find out more

France, Surgical Procedure Volumes

$4,850.00

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the EU country of France.

August 1, 2013

Find out more

Women’s Health: Trends and Opportunities in the U.S. Osteoporosis Management Market

$3,750.00

This report provides analyses of products, markets, and competitors in the United States (U.S.) market for osteoporosis management products.

September 2, 2013

Find out more

Women’s Health: U.S. Markets for Reproductive Management Products

$3,750.00

This report presents market and competitive analyses for selected leading contraceptive and fertility products as well as an overview of the most common types of contraceptives and fertility drugs/treatments available to women in the United States (U.S.) for reproductive management.

September 2, 2013

Find out more

Germany, Surgical Procedure Volumes

$4,850.00

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Germany.

October 1, 2013

Find out more

U.S. Markets, Trends, and Opportunities in Patient Monitoring Products

$4,750.00

The intensity and high acuity of the critical care environment, combined with the shortage of experienced registered nurses, means that noninvasive and minimally invasive patient monitoring products will be in great demand during the forecast period covered by this report.

November 1, 2013

Find out more

Spain, Surgical Procedure Volumes

$4,850.00

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Spain.

November 1, 2013

Find out more

Psychiatry KOL Insight Interview

$599.00

At SfN, they showed some interesting preclinical data on the affect on the 5-HT7 and how it works in some animal models of cognition…especially those injected with PCPA. And you know in depression, they also did what we call the chronic mild stress (CMS)

January 24, 2014

Find out more

Selexipag for Pulmonary Arterial Hypertension

$89.00

Areas covered: Selexipag is rapidly hydrolyzed to an active metabolite, ACT-333679. Both selexipag and its metabolite are highly selective for the IP receptor compared with other prostanoid receptors. This selectivity for the IP receptor offers the potential for improved tolerability with selexipag, as side effects (e.g., nausea and vomiting) that might result from activation of the other prostanoid receptors may be minimized.

February 1, 2014

Find out more

Palbociclib for Breast Cancer

$89.00

Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer

February 1, 2014

Find out more

NASH KOL Insight Interview #1

$599.00

The prevalence data would suggest that in the US population about 30% of our population has fatty liver or NAFLD and of those 25% may have NASH and of those patients with NASH 25% percent may have fibrosis and progress to cirrhosis. It’s almost a pyramid effect, there may be 80 million Americans walking around with NAFLD, but to climb up to the top of the pyramid and develop cirrhosis would be about 5% of that total population, but that’s still significant because that would mean that the prevalence of cirrhosis [due to NASH] will exceed that of hepatitis C-related cirrhosis ten-fold

February 20, 2014

Find out more

Macitenan for Pulmonary Arterial Hypertension

$89.00

Macitentan is a novel dual endothelin receptor antagonist (ERA)

showing sustained receptor occupancy

March 1, 2014

Find out more

Report library

France, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

Germany, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

Italy, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

Spain, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

United Kingdom, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure

Germany, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure

Italy, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

Spain, Neurological Market Opportunities: Disease Incidence and Prevalence, And Surgical Procedure Volumes

United States, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

United States, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

United States, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

U.S. Markets for Skin Replacements and Substitutes and Active Wound Repair Modulators

Current and Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Therapies

U.S. Markets for Diagnostic Oncology-Related X-Ray-Based Imaging Products

U.S. Markets for Compression Therapy and Pressure Reduction and Relief Products Used for Wound Management

U.S. Benign Uterine Conditions Therapy Systems Market

U.S. Markets for Orthopedic Biomaterials for Bone Repair and Regeneration

European Markets for Prosthetic Vascular Grafts

U.S. Markets for Orthopedic Biomaterials for Viscosupplementation and Cartilage, Ligament/Tendon, and Meniscal Repair and Regeneration

France, Surgical Procedure Volumes

Women’s Health: Trends and Opportunities in the U.S. Osteoporosis Management Market

Women’s Health: U.S. Markets for Reproductive Management Products

Germany, Surgical Procedure Volumes

U.S. Markets, Trends, and Opportunities in Patient Monitoring Products

Spain, Surgical Procedure Volumes

Psychiatry KOL Insight Interview

Selexipag for Pulmonary Arterial Hypertension

Palbociclib for Breast Cancer

NASH KOL Insight Interview #1

Macitenan for Pulmonary Arterial Hypertension